Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Conditions

• Peripheral Neuropathy
• Neuropathic Pain

Interventions

• DRUG: ADL5859
• DRUG: Duloxetine
• DRUG: Placebo

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)